ARTICLE | Clinical News
Serlopitant: Phase II data
January 5, 2015 8:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in 257 patients ages 18-65 with chronic pruritus and a VAS score of =7 points at baseline who were unresponsive or inadequately responsive to top...